Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Saccharin is a non-nutritive artificial sweetener approximately 300–500 times sweeter than sucrose. It is used to sweeten foods and beverages without adding calories and is commonly found in products such as diet drinks, candies, baked goods, pharmaceuticals (as an excipient), vitamins, toothpaste, and mouthwash[1][2][4]. Saccharin is heat-stable and does not react with other food ingredients. The most common forms are its sodium or calcium salts due to their high water solubility[1]. While primarily used as a sugar substitute for people seeking low-calorie options or those with diabetes (since it does not affect blood glucose), recent research has shown that saccharin can disrupt bacterial cell division and biofilm formation by destabilizing bacterial membranes and interfering with DNA replication—suggesting potential antimicrobial properties[6][8]. Saccharin was once linked to cancer risk in animal studies but has since been deemed safe for human consumption by regulatory authorities such as the FDA[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on saccharin.